Rheumatic Fever and Antibody Response to Group A Streptococcal Infections

Authors

  • Ganesh Prasad Neupane Lecturer, Microbiology KU MS/Dhulikhel Hospital, Nepal
  • R Makaju Dhulikhel Hospital, Kathmandu University Hospital
  • R Koju Dhulikhel Hospital, Kathmandu University Hospital

DOI:

https://doi.org/10.3126/njh.v6i1.18597

Keywords:

Rheumatic Fever, Antibody Response, Group A Streptococcal Infections

Abstract

Rheumatic fever is non-suppurative sequel of group A streptococcal infection. It is a multifocal inflammatory disease, affecting primarily the heart, joints, skin and central nervous system occurring in 0.1% to 3% after untreated pharyngitis. It was a major cause of death and a common cause of chronic structural heart disease in children until 1960. It has declined in developed countries due to advent of penicillin and improved social conditions. Rheumatic fever is very common disease among children in developing countries till date. Rheumatic fever and its clinically significant sequel, rheumatic heart disease, continue to be a major health problem in developing countries like Nepal. Rheumatic fever is still a major cause of death and heart disease.

Downloads

Download data is not yet available.
Abstract
463
PDF
580

Downloads

Published

2017-11-24

How to Cite

Neupane, G. P., Makaju, R., & Koju, R. (2017). Rheumatic Fever and Antibody Response to Group A Streptococcal Infections. Nepalese Heart Journal, 6(1), 58–61. https://doi.org/10.3126/njh.v6i1.18597

Issue

Section

Review Articles